Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 30:12:208.
doi: 10.1186/1471-2407-12-208.

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population

Daris Ferrari  1 , Carla Codecà, Cecilia Bertuzzi, Francesca Broggio, Francesca Crepaldi, Andrea Luciani, Irene Floriani, Mohssen Ansarin, Fausto Chiesa, Daniela Alterio, Paolo Foa
Affiliations

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population

Daris Ferrari et al. BMC Cancer. .

Abstract

Background: Loco-regionally advanced nasopharyngeal carcinomas can be cured by the combination of chemotherapy and radiotherapy. In Eastern countries, plasma levels of viral Epstein-Barr deoxyribonucleic acid (DNA) are accurate in predicting recurrence, but few data are available in Western populations. The aim of this prospective study was to evaluate the relationship between viral Epstein-Barr DNA copy numbers in plasma and the response rate, progression-free survival and overall survival in a cohort of Western patients with stage IIb-IVb nasopharyngeal cancer.

Methods: We evaluated plasma samples from 36 consecutive patients treated with induction chemotherapy followed by chemoradiation. EBV copy numbers were determined after DNA extraction using real-time quantitative polymerase chain reaction. Survival curves were estimated using the Kaplan-Meier method.

Results: Circulating Epstein-Barr virus DNA levels were measured before treatment, at the end of concomitant chemo- and radiotherapy, and during the follow-up period. Pre-treatment levels significantly correlated with the initial stage and probability of relapse. Their increase was 100% specific and 71.3% sensitive in detecting loco-regional or metastatic recurrence (an overall accuracy of 94.4%). Three-year progression-free and overall survival were respectively 78.2% and 97.1%.

Conclusions: The results of this study confirm that patients from a Western country affected by loco-regionally advanced nasopharyngeal carcinoma have high plasma Epstein-Barr virus DNA levels at diagnosis. The monitoring of plasma levels is sensitive and highly specific in detecting disease recurrence and metastases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meyer curves depicting progression-free survival and overall survival.
See this image and copyright information in PMC

References

    1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. VII. International Agency for Research on Cancer, Lyon; 1997. pp. 814–815. IARC Scientific Publications No.143.
    1. Parkin D. Cancer Burden in the year 2000. The global Picture. Eur J Cancer. 2001;37:S4–S66. - PubMed
    1. Nielsen NH, Mikkelsen F, Hansen JP. Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population. Acta Pathol Microbiol Scand. 1977;85:850–858. - PubMed
    1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–429. doi: 10.1016/S1044579X02000858. - DOI - PubMed
    1. Huang TB, Min HQ, Min HQ, Wang HM, Zhang EP, Hong MH. Nasopharyngeal Carcinoma Research. Guangdong Science and Technology Press, Guangzhou; 1998. pp. 6–12.